ETHICS PANEL MEETS ON MORHAIM: A panel of state lawmakers was scheduled to debate Wednesday whether to open a formal ethics inquiry into Del. Dan K. Morhaim and his ties to the medical marijuana industry he helped create, writes Erin Cox for the Sun. The confidential proceedings of the Joint Committee on Legislative Ethics was set to review a preliminary investigation by ethics staff, according to three people with direct knowledge with the situation.
Members of the Joint Committee on Legislative Ethics met for three hours but left the room with barely a word to reporters. Some just waved as questions were asked. Others slipped out the back door. A few acknowledged journalists only with a groan, reports Bryan Sears for the Daily Record.
BATTLE LINES OVER POT RX LAW: Del. Cheryl D. Glenn, co-author of the Maryland state law that permits the use of marijuana for medical purposes, says that measure needs an overhaul. Michael Bronfein is chief executive of a company that was awarded one of the state’s 15 licenses to grow medical marijuana. He says the law is the best in the country, and no changes are needed. The two took part Wednesday in a panel discussion. While their comments were cordial, their messages showed where battle lines on medical marijuana are being drawn for the 2017 General Assembly session, Michael Dresser of the Sun reports.